We would love to hear your thoughts about our site and services, please take our survey here.
From SWE on telegram regarding biosynex finances:
To me its simple, they're plain and simple going for it. I've just read through their RNSs for the year:
-A lot of talk of wanting to become a major player in Europe
-Final results for 2020 they €153m revenue and at December 2020 had a cash position of €66m
-They then bought rival test company Avalun (haven't yet found out how much for)
-They then got a finance deal which gave them access to €109m worth of financing. What do they need that for considering the cash they had? More on this later..
-They then snapped up 19% of PCR company Theradiag, which they then used to leverage a distribution deal with. This isn't a huge company, shares probably cost ~€5m so still tons left in the bank
-They then bought a branch of health care company Enalees, again not sure how much for
-They then raised nearly €4m from warrant conversion
-They then announced that their revenue in 2021 was even higher than 2020 at a whopping €382m. They will announce full results in March where we'll see just how much cash they have access to. I'm guessing despite the previous acquisitions they will have min €170m+ in cash and then have access to the €109m financing facility
...so again, why did they need to strike a financing deal when they were raking in the cash and have a huge kitty already?!
Chris, sadly I don’t think so, they seem to be a small company:
https://www.societe.com/societe/a-l-a-financiere-423688654.html
TO THE. FINANCIERE, a limited liability company, registered under SIREN 423688654, has been in business for 22 years. Based in STRASBOURG (67000), it specializes in the fund management business sector. Its workforce is between 1 and 2 employees. In 2020, it achieved a turnover of €507,600.00. Societe.com lists 2 establishments as well as an agent since the beginning of its activity, the last notable event of this company dates from 16-08-2018. Larry ABENSUR is manager of the company A.L.A. FINANCIAL.
Byp, it’s deluded to believe the Gov that COVID is over, the majority of scientists think the government have gone mad. Hospitals will continue to test patients, the mega labs may slow down and airport testing will decrease (lots of other countries require pre entry testing). The main income for us is inevitably the hospitals. I personally think we’ll be in a similar situation to last winter this winter; with minimal testing outside of hospitals the first indicator of mass infection is going to be an uptick in hospital admissions.
Whilst the market thinks COVID is done and doesn’t apply value on that basis, the company will continue to make money from it, benefiting the future plan.
Sir digby, the BMJ must have been lying when they said innova were between 30 and 70% accurate. They’re obviously over 99.9% specificity to achieve approval, yet we still haven’t.
https://www.dailymail.co.uk/news/article-10276793/Hospitalisations-Omicron-hit-South-African-province-RISING-faster-previous-wave.html
Dribbles, this has been posted before. What you’re saying isn’t fact, no one knows, only assumptions. There’s a lot of optimism out there but articles like this state the opposite of your ‘mild’ comment.
https://twitter.com/bnodesk/status/1464734073897766919?s=21
Woody, Deos the ‘mild’ comment was taken out of context, mild symptoms observed in younger adults, what that means for the elderly population is unknown.
Courtesy of Stuart:
https://www.dailymail.co.uk/news/article-10238113/New-Botswana-variant-32-horrific-mutations-evolved-Covid-strain-EVER.html
https://www.medrxiv.org/content/10.1101/2021.09.28.21264260v2
An interesting read, states the reduction in COVID-19 (Delta) transmission for vaccinated individuals is pretty much gone after 3 months. With vaccine passports COVID-19 will continue to spread freely across the globe, yes vaccines reduce morbidity and morality, however the efficacy rapidly drops off after 6 months.
COVID-19 is an endemic, testing will remain, especially in the NHS and some other countries. We may have to wait 10 years to receive a valuation of £500mil based on cash in the bank, but once thing is for certain, cash will continue to be made for many years to come.
WBAFC. The BoD aren’t sinking the SP, if they were purchasing low they’d have to announce it which isn’t happening. The comms are ****e yes, however nothing is going to budge this until the dispute is resolved, it’s tainted, short of a £100mil contract being announced. I guarantee most are on the sidelines waiting for the end of this downward trend which has been ongoing since Jan.
WBFAC, pretty impossible for them to drop to £1-1.50 as that will be less than the cash in the bank. The only way that will happen is if they spend all the money and start becoming loss making, highly unlikely.